# API Sourcing Continuity For Pharma

*/Opportunities/API_Sourcing_Continuity_For_Pharma*

## Opportunity Linked I C P

**Icp**: [Pharmaceutical Manufacturer](/CompanyTypes/Pharmaceutical_Manufacturer)

## Opportunity Linked Problem

**Problem**: Pharmaceutical Supply Chain Risk

## Opportunity Market Sizing

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**S A M**: ~$1-1.5B US and European mid-to-large pharmaceutical manufacturers
**S O M**: ~$40-80M
**T A M**: ~8,000 global pharmaceutical manufacturers and CDMOs × ~$500k/yr ≈ $4B
**Growth Rate**: ~14-19%/yr, driven by geopolitical decoupling from traditional API hubs and increasing regulatory mandates for supply chain redundancy
**Paid Comparable Spend**: ~$300k-800k/yr on dedicated procurement analyst headcount, third-party vendor audits, and generic supply chain mapping software

## Neighborhood

### Entrant startups

- [Tundraion](/Startups/Tundraion) — is entrant in · Startups

### What it addresses

- [Pharmaceutical Supply Chain Risk](/Problems/Pharmaceutical_Supply_Chain_Risk) — addresses · Problems

### Applies thesis

- [Pharmaceutical Manufacturer](/CompanyTypes/Pharmaceutical_Manufacturer) — applies thesis · CompanyTypes